New insights into the stemness of adoptively transferred T cells by γc family cytokines.
Adoptive cell therapy (ACT)
Stem cell-like memory T cells (TSCM)
Stemness
γc family cytokines
Journal
Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
30
08
2023
accepted:
11
10
2023
medline:
6
12
2023
pubmed:
5
12
2023
entrez:
4
12
2023
Statut:
epublish
Résumé
T cell-based adoptive cell therapy (ACT) has exhibited excellent antitumoral efficacy exemplified by the clinical breakthrough of chimeric antigen receptor therapy (CAR-T) in hematologic malignancies. It relies on the pool of functional T cells to retain the developmental potential to serially kill targeted cells. However, failure in the continuous supply and persistence of functional T cells has been recognized as a critical barrier to sustainable responses. Conferring stemness on infused T cells, yielding stem cell-like memory T cells (T
Identifiants
pubmed: 38049832
doi: 10.1186/s12964-023-01354-3
pii: 10.1186/s12964-023-01354-3
pmc: PMC10694921
doi:
Substances chimiques
Cytokines
0
Types de publication
Video-Audio Media
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
347Subventions
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : the National Key Technology Research and Development Program of China
ID : 2022YFC2704200
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Organisme : National Natural Science Foundation of China
ID : 82272707, 81874109
Informations de copyright
© 2023. The Author(s).
Références
Science. 2022 Dec 16;378(6625):1227-1234
pubmed: 36520914
J Transl Med. 2016 Jul 19;14(1):214
pubmed: 27435312
Cancer Immunol Res. 2017 Jul;5(7):571-581
pubmed: 28550091
Cancer Immunol Res. 2020 Mar;8(3):309-320
pubmed: 31953246
Lancet. 2021 Jul 24;398(10297):314-324
pubmed: 34175021
Clin Cancer Res. 2016 Feb 1;22(3):680-90
pubmed: 26832745
J Clin Oncol. 1999 Jul;17(7):2105-16
pubmed: 10561265
Sci Immunol. 2018 Jul 6;3(25):
pubmed: 29980618
Blood. 2013 Dec 12;122(25):4129-39
pubmed: 24055823
J Hematol Oncol. 2021 Jul 29;14(1):118
pubmed: 34325726
Science. 1994 May 13;264(5161):965-8
pubmed: 8178155
Immunity. 2012 Dec 14;37(6):1130-44
pubmed: 23159438
J Exp Med. 2002 Jun 17;195(12):1541-8
pubmed: 12070282
Cancer Immunol Res. 2015 Mar;3(3):219-27
pubmed: 25736261
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Cell. 2021 Mar 18;184(6):1575-1588
pubmed: 33675691
Nat Immunol. 2009 Jan;10(1):29-37
pubmed: 19043418
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14169-74
pubmed: 14605212
Cancer Cell. 2018 Apr 9;33(4):547-562
pubmed: 29634943
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15016-21
pubmed: 18809920
Nat Commun. 2017 May 22;8:15338
pubmed: 28530241
Hum Gene Ther Methods. 2014 Oct;25(5):277-87
pubmed: 25143008
Science. 2018 Mar 2;359(6379):1037-1042
pubmed: 29496879
Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
J Clin Invest. 2022 Feb 1;132(3):
pubmed: 35104810
Annu Rev Immunol. 2008;26:453-79
pubmed: 18062768
Nature. 2022 Oct;610(7930):173-181
pubmed: 36171288
Sci Transl Med. 2021 Dec 22;13(625):eabg7565
pubmed: 34936383
Nature. 2020 Jul;583(7817):609-614
pubmed: 32581358
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
Cancer Immunol Immunother. 2021 Oct;70(10):2781-2793
pubmed: 33634371
Science. 2022 Dec 16;378(6625):eaba1624
pubmed: 36520915
N Engl J Med. 2018 Jul 5;379(1):64-73
pubmed: 29972754
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6047-6055
pubmed: 32123114
Cancer Discov. 2021 Jun;11(6):1368-1397
pubmed: 33811048
Front Oncol. 2021 Sep 17;11:723888
pubmed: 34604060
Proc Natl Acad Sci U S A. 1989 Jan;86(1):302-6
pubmed: 2643102
J Leukoc Biol. 2021 Dec;110(6):1209-1223
pubmed: 34402104
Cancer Biol Med. 2019 Feb;16(1):109-124
pubmed: 31119051
Nat Rev Cancer. 2012 Oct;12(10):671-84
pubmed: 22996603
Immunity. 2019 Dec 17;51(6):1043-1058.e4
pubmed: 31810882
J Immunol. 2013 Sep 1;191(5):2299-307
pubmed: 23904158
Nature. 1988 Jun 9;333(6173):571-3
pubmed: 3259677
Oncotarget. 2018 Feb 7;9(17):13125-13138
pubmed: 29568345
Nat Med. 2015 Jan;21(1):55-61
pubmed: 25501905
Leukemia. 2010 Jun;24(6):1160-70
pubmed: 20428207
Diabetes. 2018 May;67(5):936-945
pubmed: 29506985
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Cancer Immunol Res. 2016 Jan;4(1):49-60
pubmed: 26511282
J Clin Oncol. 2015 Jun 10;33(17):1974-82
pubmed: 25605845
Cancer Discov. 2021 Jun;11(6):1353-1367
pubmed: 33712487
Nat Rev Immunol. 2011 May;11(5):330-42
pubmed: 21508983
Nature. 2019 Jan;565(7738):186-191
pubmed: 30626941
Immunity. 2019 Apr 16;50(4):832-850
pubmed: 30995502
J Clin Oncol. 1995 Mar;13(3):688-96
pubmed: 7884429
J Cell Mol Med. 2020 Jan;24(1):1046-1058
pubmed: 31756785
J Transl Med. 2022 Sep 27;20(1):432
pubmed: 36167591
Clin Transl Immunology. 2014 Jul 18;3(7):e20
pubmed: 25505968
N Engl J Med. 2021 Feb 25;384(8):705-716
pubmed: 33626253
Nat Med. 2017 Jan 6;23(1):18-27
pubmed: 28060797
Nat Rev Cancer. 2021 Mar;21(3):145-161
pubmed: 33483715
Nat Med. 2022 Apr;28(4):678-689
pubmed: 35440724
J Clin Invest. 2019 Mar 5;129(5):2056-2070
pubmed: 30835255
Sci Immunol. 2022 Feb 11;7(68):eabl6322
pubmed: 35148200
Front Immunol. 2021 Jul 20;12:715234
pubmed: 34354714
Nature. 2022 Jul;607(7918):360-365
pubmed: 35676488
Science. 1994 Nov 11;266(5187):1045-7
pubmed: 7973659
Cancer Immunol Res. 2019 May;7(5):759-772
pubmed: 30890531
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Nat Med. 2009 Jul;15(7):808-13
pubmed: 19525962
Int Immunopharmacol. 2021 Feb;91:107318
pubmed: 33383444
Blood. 2016 Jul 28;128(4):519-28
pubmed: 27226436
Sci Transl Med. 2021 Dec 22;13(625):eabg6986
pubmed: 34936380
Clin Cancer Res. 2014 Apr 15;20(8):2044-50
pubmed: 24737791
Nature. 1983 Mar 24-30;302(5906):305-10
pubmed: 6403867
J Immunother. 2016 Jul-Aug;39(6):233-40
pubmed: 27244531
Nature. 2021 Sep;597(7877):544-548
pubmed: 34526724
Nat Immunol. 2012 Dec;13(12):1187-95
pubmed: 23104097
Front Immunol. 2021 Oct 07;12:728962
pubmed: 34691036
Blood. 2011 Dec 22;118(26):6845-8
pubmed: 22067383
Nature. 1977 Jul 14;268(5616):154-6
pubmed: 145543
Lancet. 2021 Sep 11;398(10304):1002-1014
pubmed: 34509219
Nat Rev Immunol. 2006 Aug;6(8):595-601
pubmed: 16868550
Blood. 2013 Jan 24;121(4):573-84
pubmed: 23160470
Science. 2020 Dec 11;370(6522):1328-1334
pubmed: 33303615
Science. 2018 Mar 23;359(6382):1361-1365
pubmed: 29567707
Immunity. 2015 May 19;42(5):826-38
pubmed: 25992859
Mol Ther. 2021 Dec 1;29(12):3410-3421
pubmed: 34174441
Cancer Res. 2020 Feb 1;80(3):471-483
pubmed: 31767627
J Immunol. 2015 Jan 15;194(2):553-9
pubmed: 25480562
Nat Immunol. 2022 Jun;23(6):848-860
pubmed: 35624210
J Clin Invest. 2015 Sep;125(9):3477-90
pubmed: 26241055
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1833-1838
pubmed: 29229383
J Immunol. 2008 Feb 15;180(4):2099-106
pubmed: 18250415
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11439-44
pubmed: 11016959
Nat Rev Immunol. 2015 May;15(5):295-307
pubmed: 25848755
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4940-4
pubmed: 8197161
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34896980
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
Nature. 2012 Mar 25;484(7395):529-33
pubmed: 22446627
Nat Metab. 2020 Oct;2(10):1001-1012
pubmed: 32958939
J Immunol. 2021 Nov 15;207(10):2489-2500
pubmed: 34654688
J Exp Med. 2010 Sep 27;207(10):2175-86
pubmed: 20819923
Nat Rev Immunol. 2011 Oct 25;11(11):716
pubmed: 22025045
Annu Rev Immunol. 2018 Apr 26;36:411-433
pubmed: 29677473
Nat Commun. 2021 Feb 11;12(1):951
pubmed: 33574265
Immunity. 2010 Jan 29;32(1):79-90
pubmed: 20096607
Nature. 2000 Nov 2;408(6808):57-63
pubmed: 11081504
J Hematol Oncol. 2022 Mar 12;15(1):24
pubmed: 35279217
Nat Rev Immunol. 2022 Oct;22(10):614-628
pubmed: 35217787
Annu Rev Immunol. 2015;33:139-67
pubmed: 25493332
Sci Transl Med. 2022 Jul 13;14(653):eabl4106
pubmed: 35857642
J Immunother Cancer. 2022 Apr;10(4):
pubmed: 35379739
Nature. 2019 Dec;576(7787):465-470
pubmed: 31827286
J Leukoc Biol. 2017 Aug;102(2):499-506
pubmed: 28588029
Blood. 2014 Jun 12;123(24):3750-9
pubmed: 24782509
Cell Res. 2021 Nov;31(11):1190-1198
pubmed: 34376814
N Engl J Med. 1987 Apr 9;316(15):889-97
pubmed: 3493432
Nat Immunol. 2019 Mar;20(3):337-349
pubmed: 30778251
Nat Immunol. 2000 Nov;1(5):426-32
pubmed: 11062503
Oncoimmunology. 2021 Sep 27;10(1):1983306
pubmed: 34595061
Nat Med. 2018 May;24(5):563-571
pubmed: 29713085
N Engl J Med. 2022 Dec 8;387(23):2113-2125
pubmed: 36477031
Trends Immunol. 2015 Dec;36(12):763-777
pubmed: 26572555
J Biol Chem. 2006 Jan 20;281(3):1612-9
pubmed: 16284400
J Exp Med. 2022 Dec 5;219(12):
pubmed: 36165896
Immunol Rev. 2008 Apr;222:357-68
pubmed: 18364014
Trends Immunol. 2014 Feb;35(2):51-60
pubmed: 24210163
Nat Med. 2005 Dec;11(12):1299-305
pubmed: 16288282
Nat Immunol. 2019 Feb;20(2):195-205
pubmed: 30643267
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
Nat Rev Immunol. 2018 Feb;18(2):91-104
pubmed: 28990586
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Nat Commun. 2023 Aug 7;14(1):4737
pubmed: 37550294
Nat Protoc. 2013 Jan;8(1):33-42
pubmed: 23222456
Immunol Rev. 2006 Feb;209:274-83
pubmed: 16448548
Trends Immunol. 2022 Oct;43(10):833-847
pubmed: 36058806
Cell Rep Med. 2023 Mar 17;:100978
pubmed: 36933554
Nature. 2022 Oct;610(7930):161-172
pubmed: 36171284
Nature. 1987 Jul 16-22;328(6127):267-70
pubmed: 3496540
J Hepatol. 2020 Sep;73(3):640-650
pubmed: 32247824
N Engl J Med. 2013 Jul 11;369(2):122-33
pubmed: 23724867
Immunity. 2020 May 19;52(5):825-841.e8
pubmed: 32396847
Clin Cancer Res. 2019 May 1;25(9):2915-2924
pubmed: 30617136
PLoS One. 2012;7(7):e41074
pubmed: 22859966
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7788-E7797
pubmed: 27849617
Nat Rev Cancer. 2021 Aug;21(8):481-499
pubmed: 34083781
Cytokine Growth Factor Rev. 2016 Oct;31:49-59
pubmed: 27325459
PLoS One. 2017 Jul 5;12(7):e0179431
pubmed: 28678791
Sci Transl Med. 2020 Jun 24;12(549):
pubmed: 32581136
Cancer Immunol Res. 2019 Sep;7(9):1426-1439
pubmed: 31308016
Int Immunopharmacol. 2018 Sep;62:29-39
pubmed: 29990692
J Immunol. 2001 Dec 15;167(12):6869-76
pubmed: 11739504
J Immunother. 2017 Jan;40(1):1-10
pubmed: 27828929
Blood. 2010 Oct 28;116(17):3238-48
pubmed: 20631381
Infect Immun. 2022 Oct 20;90(10):e0025922
pubmed: 36190256
J Biol Chem. 2013 Jun 21;288(25):18093-103
pubmed: 23649624
J Immunol. 2009 Jun 1;182(11):6659-69
pubmed: 19454660
Nat Rev Immunol. 2019 Nov;19(11):665-674
pubmed: 31570879
Cell. 2015 May 7;161(4):750-61
pubmed: 25957683
Nature. 2022 Sep;609(7926):354-360
pubmed: 35978192
Nature. 2003 Dec 11;426(6967):671-6
pubmed: 14668867
Clin Cancer Res. 2012 Jun 1;18(11):3022-9
pubmed: 22510350
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31611250
Blood. 2013 Jan 24;121(4):567-8
pubmed: 23349370
Semin Immunol. 2009 Apr;21(2):62-8
pubmed: 19269852
Science. 2012 Nov 30;338(6111):1220-5
pubmed: 23197535
Cell Mol Immunol. 2021 Feb;18(2):279-293
pubmed: 33177696
Immunity. 2010 Jan 29;32(1):91-103
pubmed: 20096608
Nature. 2021 Jul;595(7865):101-106
pubmed: 34108686
Nat Immunol. 2016 Nov;17(11):1322-1333
pubmed: 27595233
J Immunol. 2005 Jun 1;174(11):6571-6
pubmed: 15905493
Science. 1976 Sep 10;193(4257):1007-8
pubmed: 181845
Blood. 2008 Jun 1;111(11):5326-33
pubmed: 18276844
J Exp Med. 2002 Sep 16;196(6):851-7
pubmed: 12235217
J Mol Cell Biol. 2010 Aug;2(4):217-22
pubmed: 20671116
Immunity. 2013 Jan 24;38(1):131-9
pubmed: 23260193
J Exp Med. 2010 Sep 27;207(10):2187-94
pubmed: 20819927
Cancer Immunol Res. 2022 Feb;10(2):146-153
pubmed: 34937730
Eur J Immunol. 2017 Sep;47(9):1468-1476
pubmed: 28671275
Cytotherapy. 2015 Apr;17(4):487-95
pubmed: 25573334
Cytotherapy. 2022 Aug;24(8):767-773
pubmed: 35597752
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80
pubmed: 20385810
Clin Exp Immunol. 2016 Nov;186(2):249-265
pubmed: 27227483
Nat Biotechnol. 2020 Feb;38(2):233-244
pubmed: 31907405
Nat Rev Immunol. 2007 Feb;7(2):144-54
pubmed: 17259970
Nat Rev Drug Discov. 2022 Jul;21(7):509-528
pubmed: 34937915
Cancer Sci. 2018 Jul;109(7):2130-2140
pubmed: 29790621
EBioMedicine. 2016 Jan 16;4:50-61
pubmed: 26981571
Cancer Discov. 2019 Jun;9(6):711-721
pubmed: 30988166
Nat Immunol. 2022 Jun;23(6):868-877
pubmed: 35618829
Immunity. 2004 Aug;21(2):289-302
pubmed: 15308108
Nat Rev Immunol. 2018 Oct;18(10):648-659
pubmed: 30089912
Science. 2020 Feb 28;367(6481):
pubmed: 32029687
J Immunother. 2018 Jul/Aug;41(6):274-283
pubmed: 29864078
Am J Transplant. 2014 Jun;14(6):1277-89
pubmed: 24842641